Insight in North America

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
Report
Report

Coalbed Methane

Opportunities and Competition in an Evolving Global Market 2010

Published By Datamonitor
01 Oct 2010 $2750
Buy
Brief
Brief

Coconut Water Case Study: Consolidating Growth in a Burgeoning Segment

Assesses the market development of a high growth non-alcoholic drinks segment in the US and what leading category players are doing to consolidate their market position

Published By Datamonitor
30 Nov 2010 $400
Buy
Company Report
Company Report

Coconut Water Case Study: responding to consumer health demands with a novel juice product

This case study looks at the emergence of coconut water as a new driver of market growth in the US juice market and examines the major players within the sector, namely Vita Coco, Zico and ONE.

Published By Datamonitor
15 Mar 2010 $295
Buy
Brief
Brief

Comcast's TV Everywhere experiment goes beyond Xfinity

Analysis of Comcast's thePlatform-powered TV Everywhere strategy and the implications for its proposed acquisition of NBC Universal

Published By Datamonitor
14 Jan 2010 $150
Buy
Report
Report

Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential

Analysis of the future potential of anticonvulsants market. Includes sales forecasts over 2009-2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) of key marketed brands, generics, and pipeline agents.

Published By Datamonitor
08 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market

Analysis of the current and future antidepressant drug class market. Includes sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
08 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion

Analysis of the current and future antipsychotic market. Includes country-specific sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
28 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Cardiovascular and Metabolic Market Overview – Strong diabetes growth not enough to stop CV market from declining

In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the Datamonitor forecast period (2010–19).

Published By Datamonitor
03 Feb 2011 $15200
Buy
Report
Report

Commercial Insight: Disease Modification in Rheumatoid Arthritis – Market awaits game changing therapies and strategies

Coverage of disease-modifying drugs in the seven major rheumatoid arthritis markets, including indication-specific 10-year forecasts (using both sales and patient-based approaches), detailed brand profiling and an in-depth patient-based case study.

Published By Datamonitor
15 Dec 2010 $15200
Buy
Report
Report

Commercial Insight: Hormonal Contraceptives - Look beyond oral contraception for a competitive edge

Full analysis of the current and future hormonal contraceptives drug market, with country-specific forecasts to 2018 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published By Datamonitor
02 Oct 2009 $15200
Buy

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.